newsfilter
← Latest News
PR Newswire·

Galmed Announces Meaningful Top Line Results from AM-001 Study of Aramchol Meglumine

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, ...